MA41378A - Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol - Google Patents

Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol

Info

Publication number
MA41378A
MA41378A MA041378A MA41378A MA41378A MA 41378 A MA41378 A MA 41378A MA 041378 A MA041378 A MA 041378A MA 41378 A MA41378 A MA 41378A MA 41378 A MA41378 A MA 41378A
Authority
MA
Morocco
Prior art keywords
dry powder
powder inhaler
fluticasone propionate
salmeterol xinafoate
inhaler consisting
Prior art date
Application number
MA041378A
Other languages
English (en)
Inventor
Mukul Dalvi
Seah Kee Tee
Original Assignee
Teva Branded Pharmaceutical Prod R & D Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55443303&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41378(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Branded Pharmaceutical Prod R & D Inc filed Critical Teva Branded Pharmaceutical Prod R & D Inc
Publication of MA41378A publication Critical patent/MA41378A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0005—Details of inhalators; Constructional features thereof with means for agitating the medicament
    • A61M15/0006—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means
    • A61M15/0008—Details of inhalators; Constructional features thereof with means for agitating the medicament using rotating means rotating by airflow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
MA041378A 2015-01-20 2016-01-19 Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol MA41378A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562105479P 2015-01-20 2015-01-20

Publications (1)

Publication Number Publication Date
MA41378A true MA41378A (fr) 2017-11-28

Family

ID=55443303

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041378A MA41378A (fr) 2015-01-20 2016-01-19 Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol

Country Status (19)

Country Link
US (2) US9415008B2 (fr)
EP (1) EP3247331A1 (fr)
JP (1) JP2018503687A (fr)
KR (1) KR20170103975A (fr)
CN (1) CN107530357A (fr)
AR (1) AR104771A1 (fr)
AU (2) AU2016209363B2 (fr)
BR (1) BR112017015353A2 (fr)
CA (1) CA2974125A1 (fr)
CL (1) CL2017001859A1 (fr)
CO (1) CO2017008395A2 (fr)
EA (1) EA201791632A1 (fr)
HK (1) HK1245125A1 (fr)
IL (1) IL253499A0 (fr)
MA (1) MA41378A (fr)
MX (2) MX2017009122A (fr)
PE (1) PE20171258A1 (fr)
TW (1) TW201628607A (fr)
WO (1) WO2016118589A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016007771B1 (pt) * 2013-10-07 2023-03-28 Teva Branded Pharmaceutical Products R&D, Inc. Inalador de pó seco e uso de propionato de fluticasona e salmeterol
MA41378A (fr) * 2015-01-20 2017-11-28 Teva Branded Pharmaceutical Prod R & D Inc Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol
US11344685B2 (en) 2016-11-18 2022-05-31 Norton (Waterford) Limited Drug delivery device with electronics
CN110201281B (zh) * 2018-02-28 2021-08-06 张江 吸入给药装置和吸入给药组合结构
CN110201278B (zh) * 2018-02-28 2021-07-30 张江 用于吸入给药的药盒和吸入给药组合结构
CN110201280B (zh) * 2018-02-28 2021-07-30 张江 用于吸入给药装置的吸嘴和吸入给药装置
CN110064110A (zh) * 2019-05-29 2019-07-30 上海理工大学 一种容积旋钮式干粉储存吸入装置
GB2585206B (en) * 2019-07-01 2021-08-11 Merxin Ltd Portable inhaler

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
US6395300B1 (en) 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
AR028747A1 (es) 2000-06-23 2003-05-21 Norton Health Care Ltd Desaglomerador para inhalador de polvo seco accionado por la respiracion, un inhalador de polvo seco y un metodo de desaglomeracion de polvo seco.
TWI224512B (en) * 2000-06-23 2004-12-01 Norton Healthcare Ltd Reservoir pressure system for medicament inhaler
AR030516A1 (es) * 2000-08-31 2003-08-20 Glaxo Group Ltd Uso de una combinacion de salmeterol y fluticasona
DK2283817T3 (en) * 2000-11-30 2016-09-05 Vectura Ltd Process for preparing particles for use in a pharmaceutical composition
GB0124523D0 (en) 2001-10-12 2001-12-05 Glaxo Group Ltd Pharmaceutical combination
KR20050056222A (ko) 2002-09-30 2005-06-14 아쿠스피어 인코포레이티드 흡입용 지속 방출형 다공성 미세입자
US9114081B2 (en) * 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
CA2763941A1 (fr) * 2009-05-29 2010-12-02 Pearl Therapeutics, Inc. Compositions, methodes et systemes permettant une administration par voie respiratoire de deux principes actifs ou plus
CN102573886A (zh) * 2009-09-17 2012-07-11 相互制药公司 用抗病毒剂治疗哮喘的方法
GB0919465D0 (en) * 2009-11-06 2009-12-23 Norton Healthcare Ltd Airflow adaptor for a breath-actuated dry powder inhaler
PL2987522T3 (pl) * 2010-05-18 2019-07-31 Ivax Pharmaceuticals Ireland Liczniki dawek do inhalatorów
EP2571486A4 (fr) * 2010-05-20 2013-12-04 Sun Pharma Advanced Res Co Ltd Composition d'inhalation à poudre sèche
KR20130140358A (ko) * 2012-06-14 2013-12-24 한미약품 주식회사 살메테롤 지나포산염, 플루티카손 프로피오네이트 및 티오트로피움 브로마이드를 포함하는 흡입 제형용 건조 분말 및 이의 제조방법
KR20160030086A (ko) * 2013-04-29 2016-03-16 사노피 에스에이 흡입식 약학적 조성물 및 그를 포함하는 흡입기 장치
BR112016007771B1 (pt) * 2013-10-07 2023-03-28 Teva Branded Pharmaceutical Products R&D, Inc. Inalador de pó seco e uso de propionato de fluticasona e salmeterol
MA41378A (fr) * 2015-01-20 2017-11-28 Teva Branded Pharmaceutical Prod R & D Inc Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol

Also Published As

Publication number Publication date
AU2016209363A1 (en) 2017-08-24
EP3247331A1 (fr) 2017-11-29
EA201791632A1 (ru) 2017-12-29
US9415008B2 (en) 2016-08-16
US20180015035A1 (en) 2018-01-18
BR112017015353A2 (pt) 2018-01-16
AU2016209363B2 (en) 2021-02-04
AU2021202784A1 (en) 2021-05-27
KR20170103975A (ko) 2017-09-13
HK1245125A1 (zh) 2018-08-24
CN107530357A (zh) 2018-01-02
PE20171258A1 (es) 2017-08-28
JP2018503687A (ja) 2018-02-08
WO2016118589A1 (fr) 2016-07-28
CL2017001859A1 (es) 2018-04-06
CO2017008395A2 (es) 2018-01-05
AR104771A1 (es) 2017-08-16
MX2017009122A (es) 2017-10-12
MX2021006751A (es) 2021-07-15
US20160206559A1 (en) 2016-07-21
IL253499A0 (en) 2017-09-28
CA2974125A1 (fr) 2016-07-28
TW201628607A (zh) 2016-08-16

Similar Documents

Publication Publication Date Title
MA41378A (fr) Inhalateur de poudre sèche comprenant du propionate de fluticasone et du xinafoate de salmétérol
HK1258955A1 (zh) 干粉吸入器
GB201516558D0 (en) An inhalable composition and an inhaler
DK3612259T3 (da) Enhedsdosistørpulverinhalator
MA40688A (fr) Anticorps humains contre la protéine de pic monoclonal du coronavirus du syndrome respiratoire du moyen-orient
DK3160555T3 (da) Tørpulverinhalator og inhalationsaktiveret mekanisme deraf
HK1256041A1 (zh) 乾粉吸入器
EP3283151A4 (fr) Inhalateur de poudre sèche et procédé d'utilisation
MA47816A (fr) Composition pharmaceutique comprenant du sélexipag
IL252047A0 (en) Dry powder inhaler
IL265881A (en) Inhaler and methods of use thereof
IL263365A (en) Dry powder inhaler
MA52437A (fr) Une formulation de poudre sèche contenant un anticholinergique, un corticoïde et un bêta-adrénergique
PL3138601T3 (pl) Inhalator suchego proszku
DK3116570T3 (da) Inhalator
FI20155791A (fi) Tuote ja menetelmä
IL248875A0 (en) Combinations of formoterol and budesonide for the treatment of chronic obstructive pulmonary disease
SG11201913176UA (en) Simulated respiratory tract
DK3621682T3 (da) Tørpulverinhalator
DK3568181T3 (da) Inhalator
DK3151893T6 (da) Åndedrætsaktiveret tørpulverinhalator
GB201403009D0 (en) Dry powder cleaning compositons and packing methodologies
GB2525226B (en) Metered dose inhaler canister and shroud
IL251478A0 (en) A pharmaceutical compound containing budesonide and formoterol
GB201514554D0 (en) Design and formulation of nanoemlsions for upper respiratory tract infectious diseases and food preservation using Thymus Daenensis essential oil,